1. Home
  2. JYNT vs VYGR Comparison

JYNT vs VYGR Comparison

Compare JYNT & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JYNT
  • VYGR
  • Stock Information
  • Founded
  • JYNT 2010
  • VYGR 2013
  • Country
  • JYNT United States
  • VYGR United States
  • Employees
  • JYNT N/A
  • VYGR N/A
  • Industry
  • JYNT Multi-Sector Companies
  • VYGR Biotechnology: Pharmaceutical Preparations
  • Sector
  • JYNT Miscellaneous
  • VYGR Health Care
  • Exchange
  • JYNT Nasdaq
  • VYGR Nasdaq
  • Market Cap
  • JYNT 170.3M
  • VYGR 231.9M
  • IPO Year
  • JYNT 2014
  • VYGR 2015
  • Fundamental
  • Price
  • JYNT $10.02
  • VYGR $4.26
  • Analyst Decision
  • JYNT Strong Buy
  • VYGR Strong Buy
  • Analyst Count
  • JYNT 3
  • VYGR 8
  • Target Price
  • JYNT $16.33
  • VYGR $16.71
  • AVG Volume (30 Days)
  • JYNT 82.6K
  • VYGR 664.7K
  • Earning Date
  • JYNT 11-06-2025
  • VYGR 11-11-2025
  • Dividend Yield
  • JYNT N/A
  • VYGR N/A
  • EPS Growth
  • JYNT N/A
  • VYGR N/A
  • EPS
  • JYNT N/A
  • VYGR N/A
  • Revenue
  • JYNT $53,449,713.00
  • VYGR $42,580,000.00
  • Revenue This Year
  • JYNT $8.06
  • VYGR N/A
  • Revenue Next Year
  • JYNT $11.18
  • VYGR $107.07
  • P/E Ratio
  • JYNT N/A
  • VYGR N/A
  • Revenue Growth
  • JYNT 277.36
  • VYGR N/A
  • 52 Week Low
  • JYNT $9.58
  • VYGR $2.65
  • 52 Week High
  • JYNT $13.47
  • VYGR $8.28
  • Technical
  • Relative Strength Index (RSI)
  • JYNT 32.25
  • VYGR 63.67
  • Support Level
  • JYNT $9.85
  • VYGR $4.04
  • Resistance Level
  • JYNT $10.74
  • VYGR $4.51
  • Average True Range (ATR)
  • JYNT 0.20
  • VYGR 0.30
  • MACD
  • JYNT -0.05
  • VYGR 0.04
  • Stochastic Oscillator
  • JYNT 18.68
  • VYGR 77.62

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has one operating business segment; The Franchise Operations segment which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the Company's franchise license, which represents symbolic intellectual property.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: